Indeed. ESS could get accelerated approval after P
Post# of 30027
Posted On: 03/04/2015 10:35:42 AM
Re: the gipper #17545
Indeed. ESS could get accelerated approval after P2 as long as the data is good. It would essentially be a conditional approval requiring AMBS to conduct confirmatory P3 study, but the product would be available on the market. I assume that is covered in their 2-4 year launch estimate.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼